CRF2 mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats

Javier Navarro-Zaragoza, Cristina Núñez, Jessica Ruiz-Medina, M Luisa Laorden, Olga Valverde, M Victoria Milanés
  • British Journal of Pharmacology, January 2011, Wiley
  • DOI: 10.1111/j.1476-5381.2010.01090.x

10.1016/j.neuint.2010.06.011

The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Cristina Núñez

In partnership with: